Fiscal period ending 2025-12-31 versus 2024-12-31
— view filing on EDGAR →
Tariff costs crystallized at $50M incremental in 2025, leverage rose meaningfully with debt up $200M to $2.2B and credit facility utilization climbing, and Eurozone macro exposure widened on multiple fronts — together representing a real, broad-based deterioration in the risk profile. The shift from hypothetical to realized cost impacts across tariffs and OECD minimum tax removes prior optionality and locks in a higher cost base. Tightening liquidity headroom alongside rising leverage is the most actionable near-term concern for credit and counterparty monitors.
1 company-specific
· 2 common-mode
Company-specific changes
Revised
Debt increased from $2.0B to $2.2B; credit facility borrowings rose from $734.7M to $813.7M, reducing available liquidity and increasing leverage risk materially.
Risks Related to Our Debt We have debt and we may incur substantially more debt, which could affect our financial position and may otherwise restrict our activities. We have debt and we may incur…
Also disclosed — common-mode (Tariffs trade policy, Geopolitical macro uncertainty)
Tariffs trade policy
Revised
Tariffs shifted from hypothetical to realized: $50M incremental cost in 2025. OECD minimum tax changed from "proposed" to "adopted." Concrete financial impact disclosed.
Legal, Tax, Regulatory, and Other Risks Unanticipated changes in our tax rates or additional income tax liabilities could impact our profitability. We are subject to income taxes in the United States…
Geopolitical macro uncertainty
Revised
Eurozone risk escalated: new specific triggers (rising interest rates, defense spending, slow growth) and currency exposure increased from $39M to $53.7M on 5% USD weakening.
Table of Contents Strategic Risks A prolonged downturn or additional consolidation in the pharma/biopharmaceutical, food manufacturing, and chemical industries could adversely affect our operating…